Living With Severe Pulmonary Arterial Hypertension Without an Infusion Pump? Selexipag has a Role to Play

Arch Bronconeumol (Engl Ed). 2019 Feb;55(2):102-103. doi: 10.1016/j.arbres.2018.03.010. Epub 2018 Jul 27.
[Article in English, Spanish]
No abstract available

Publication types

  • Case Reports
  • Letter

MeSH terms

  • Acetamides / therapeutic use*
  • Antihypertensive Agents / therapeutic use*
  • Drug Substitution
  • Drug Therapy, Combination
  • Epoprostenol / analogs & derivatives
  • Epoprostenol / therapeutic use
  • Female
  • Humans
  • Infusion Pumps
  • Middle Aged
  • Phenylpropionates / therapeutic use
  • Pulmonary Arterial Hypertension / drug therapy*
  • Pyrazines / therapeutic use*
  • Pyridazines / therapeutic use
  • Sildenafil Citrate / therapeutic use
  • Tadalafil / therapeutic use
  • Vasodilator Agents / therapeutic use

Substances

  • Acetamides
  • Antihypertensive Agents
  • Phenylpropionates
  • Pyrazines
  • Pyridazines
  • Vasodilator Agents
  • selexipag
  • Tadalafil
  • Sildenafil Citrate
  • Epoprostenol
  • ambrisentan
  • treprostinil